Cargando…
Endothelin and Endothelin Antagonists in Chronic Kidney Disease
The incidence and prevalence of chronic kidney disease (CKD), with diabetes and hypertension accounting for the majority of cases, is on the rise, with up to 160 million individuals worldwide predicted to be affected by 2020. Given that current treatment options, primarily targeted at the renin angi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216619/ https://www.ncbi.nlm.nih.gov/pubmed/24805108 http://dx.doi.org/10.1038/ki.2014.143 |